Annual general meeting,
Sale,
Annual,
Self-publishing,
Invitation,
Proxy,
ART,
CHF,
Interim,
Bank statement,
AGM,
Holding company Shareholders of Evolva Holding SA in liquidation approve BoD proposals at AGM; revocation of liquidation and delisting also approved whereas introduction of opting-out was rejected
Key Points:
- Shareholders of Evolva Holding SA in liquidation approve BoD proposals at AGM; revocation of liquidation and delisting also approved whereas introduction of opting-out was rejected
PRESS RELEASE | AD HOC ANNOUNCEMENT PURSUANT TO ART.
- Reinach, Switzerland, 12 April 2024 — Evolva Holding SA in liquidation (SIX: EVE) (“Evolva”) today held its Annual General Meeting (“AGM”) in Basel.
- The shareholders approved the proposals put forward by the board of directors with large majorities.
- They also approved Nice & Green SA’s proposals to revoke the liquidation resolution and the delisting resolution, but rejected the proposal to introduce an opting-out clause in the articles of association.
Retrieved on:
Saturday, December 30, 2023
Marketing,
EGM,
Sale,
SIX Swiss Exchange,
Person,
Approval,
Amendment,
Beat,
Bacteria,
Dissolution,
Holding company Shareholders approve the sale of Evolva AG to Lallemand Inc. Swiss subsidiary at extraordinary general meeting
Key Points:
- Shareholders approve the sale of Evolva AG to Lallemand Inc. Swiss subsidiary at extraordinary general meeting
Shareholders approve the sale of Evolva AG to Lallemand Inc. Swiss subsidiary at extraordinary general meeting
Reinach, 21 December 2023 — The shareholders of Evolva Holding SA (SIX: EVE), a pioneer in the field of natural molecules and industrial biotech, approved all the proposals put forward by the Board of Directors at today’s extraordinary general meeting (EGM).
- The shareholders approved with large majorities (see details below) all proposals put forward by the Board of Directors: In particular, the sale by Evolva Holding SA of Evolva AG to Danstar Ferment AG, a Swiss affiliate of Lallemand Inc., was approved which secures the future of Evolva’s operations.
- We would like to thank the Evolva shareholders for their support in securing the future of Evolva AG’s operations.”
The convocation of an EGM became necessary after Evolva Holding SA signed, on 20 November 2023, a share purchase agreement with Danstar Ferment AG regarding the sale of all shares in Evolva Holding SA’s wholly owned subsidiary Evolva AG.
- Agenda item 5 (Delisting of Evolva Holding SA from SIX Swiss Exchange): with 91.10% of the votes represented (votes represented: 3,052,011 votes of the total outstanding shares/votes of 6,827,012).
Reinach, 24 April 2023 — Evolva (SIX: EVE), a pioneer in the field of natural molecules and industrial biotech, today communicates on the timeline of the reverse stock split of 250:1 which was approved by shareholders at the Annual General Meeting on 18 April 2023 by a large majority:
Key Points:
- Reinach, 24 April 2023 — Evolva (SIX: EVE), a pioneer in the field of natural molecules and industrial biotech, today communicates on the timeline of the reverse stock split of 250:1 which was approved by shareholders at the Annual General Meeting on 18 April 2023 by a large majority:
The reverse split of shares may result in fractions of new registered shares for the individual shareholder.
- This is the case if shareholders hold an amount of Evolva shares that is not divisible by 250 or a multiple thereof after the 25 April 2023.
- Fractions in new shares are rounded down to the next whole number and shareholders will receive an equivalent cash compensation for their fractions.
Executive,
Compensation,
Execution management system,
Annual,
AGM,
Article,
Management,
Senior,
Growth,
Consolidated,
Professional Football Compensation Committee,
CHF,
Articles of association,
Reverse,
Proxy,
Holding company,
Security (finance),
Financial adviser,
Evolva Shareholders approved all proposals put forward by the Board of Directors by a large majority.
Key Points:
- Shareholders approved all proposals put forward by the Board of Directors by a large majority.
- Discharge from liability of the members of the Board of Directors and the Executive Management for the fiscal year 2022.
- Reverse stock split: the consolidation of the Evolva shares with a reverse split ratio of 250:1.
- Furthermore, shareholders approved the ordinary capital increase for fractional compensation of CHF 11.45 as needed for the implementation of the reverse stock split.
Hair,
Senior,
Research,
Science,
Oxidative stress,
System,
Human,
News,
Skin,
Fine chemical,
Cosmetics,
Management,
Evolva,
Resveratrol Evolva is globally launching an exclusive line of nature-based high-purity ingredients and bio-functionals for the personal care industry, produced in a sustainable manner
Key Points:
- Evolva is globally launching an exclusive line of nature-based high-purity ingredients and bio-functionals for the personal care industry, produced in a sustainable manner
Reinach, 28 March 2023 — Evolva (SIX: EVE), a pioneer in the field of natural molecules and industrial biotech, will launch its “Responsible Care” program for the personal care industry at the trade fair in-cosmetics in Barcelona, Spain, on 28-30 March 2023.
- Specifically, Evolva at in-cosmetics will be featuring an exclusive line of two responsible ingredients and their powerful science: JUNEO and LARALLY.
- Evolva has created a number of responsible product concepts for the event and will promote them under the headline: Think customagic!
- Anne De Vos, Chief Commercial Officer of Evolva, comments:” We are very excited about the launch of our line of responsible active ingredients for the personal care industry.
